Invitational Ministerial Summit:
The benefits of responsible use of medicines
Setting policies for better and cost effective healthcare
Official Reports now released by the Dutch Ministry of Health, Welfare and Sport. Click below for specific translations.
Click here to download the official programme of the Summit from 3 October 2012
Medicines continue to have unprecedented positive effects on health, leading to reduced mortality, decreased disease severity and to improved quality of life. These advances, however, have come at substantial costs: pharmaceutical expenditures account for one fifth or more of all health spending in a number of countries, with medicines expenditures continuing to increase as part of overall increases in health care expenditures. Across OECD countries (high and middle income), health spending per capita since 2000 has increased more than twice as fast as economic growth on average, leading to questions about the sustainability of the system.
There is, however, significant ‘missed potential’ in the way medicines are used. For example, the right medicine does not always reach the right patient, nor do patients consistently receive correct dosages - some 50% of all patients fail to take their medicines correctly. Many diseases are thus not optimally treated, leading to negative outcomes for patients including more expensive interventions, higher social security expenses or lost economic potential due to the inability to contribute to the labour force. These negative outcomes stretch far beyond individual patients to affect health systems and society as a whole.
The Ministry of Health of the Netherlands took the lead to address this ‘missed potential’ and planned a Ministers Summit to formulate practical solutions to make the use of medicines both more responsible and more cost-effective.
The Summit focused on:
- Responsible use of medicines (the right medicine in a correct dose for the right patient at the right time)
- Unlocking the full potential of prescribers, pharmacists, nurses and other healthcare professionals
- Sharing and translation of best practices and experiences from countries with measurable successes
Input from Experts in the field - The Technical Reports
To maintain a broad vision in this Summit, input from different sources will be brought to the table: stakeholder groups will be heard, a briefing paper provided and two technical reports from The World Health Organization and the IMS Institute presented.
Experts from WHO and IMS reports, commissioned by the Ministry of Health, Welfare and Sport of The Netherlands, will each provide the Summit with a Technical Report. The two reports will focus on new policy options, policies that have been proven effective and improve a responsible use of medicines. These reports will help to formulate practical measures, measures that are relevant and can be implemented across income levels from different countries.
Click here to visit the IMS Website on Responsible Use of Medicines to read their report entitled
“The responsible use of medicines: Applying levers for change”
Click here to visit the WHO Website to download their report entitled "The Responsible Use of Medicines: Sharing and Learning from Country Experiences"
The platform - a vast specturm of stakeholders present
Stakeholders attending the Summit represented a wide range of disciplines, such as patient organisations, scientists, pharmaceutical industry, public health services and ICT-organisations. During the first morning session of the summit a hearing was held to introduce the most relevant outcomes of the FIP High-Level Stakeholders Roundtables, which acted as a foundation for discussion throughout the day.
This Summit was not a onetime event, with the Ministry of Health of the Republic of Ireland organising a First Global Forum for Chief Pharmacists in conjuction with the FIP Congress 2013 in Dublin, Ireland.